Sakar Healthcare Fair Value

Sakar Healthcare (SAKAR) average fair value is ₹197.35 across 8 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹618.6 (-68.1%), fair value range ₹27.84–₹495.61. For live price and a broader fundamental view, visit SAKAR stock overview.

Average Fair Value
₹197.35
Current Market Price: ₹618.6
-68.1% Price Difference

Fair Value Analysis Export

SAKAR Fair Value vs Current Price — Valuation Summary

SAKAR average fair value, fair value range, price gap and valuation status across 8 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF). Explore SAKAR value investing to estimate fundamental worth using multiple valuation models.

Average Fair Value
₹197.35
Current Market Price
₹618.6
Price Difference
₹-421.25
Percentage Difference
-68.1%
Fair Value Range
₹27.84 - ₹495.61
Methods Used
8
Analysis based on 8 valuation methods: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF)

P/E Based Valuation

Current EPS ₹2.03
Sector Avg P/E 6.15
Historical Avg P/E N/A
Average Fair Value
₹27.84

P/B Based Valuation

Book Value/Share ₹130.0
Sector Avg P/B 4.98
Historical Avg P/B N/A
Average Fair Value
₹421.2

Price-to-Sales Valuation

Revenue/Share ₹26.52
Sector Avg P/S 4.0
Fair Value
₹106.07

Asset-Based Valuation

Book Value/Share ₹130.0
Liquidation Value/Share ₹132.05
Fair Value
₹130.0

Earnings Growth Model (PEG)

Current EPS ₹2.03
Growth Rate 23.92%
Fair P/E Ratio 23.92
Fair Value
₹48.56

Peter Lynch Fair Value

Current EPS ₹11.39
Growth Rate 23.92%
Dividend Yield 0%
Lynch Factor 23.92
Fair P/E Ratio 23.92
Data Source Quarterly Data (5 years)
Fair Value (Lynch Factor Adjusted)
₹272.46

Benjamin Graham Number

Current EPS ₹2.03
Book Value/Share ₹130.0
Graham Multiplier 22.5
Current P/E 51.98
Graham Criteria 0/3
Graham Number
₹77.06

Discounted Cash Flow (DCF)

Current FCF ₹34.0 Cr
FCF Growth Rate 22.7%
Discount Rate 10.0%
Terminal Growth 3.0%
Enterprise Value ₹1102.72 Cr
DCF Fair Value
₹495.61

SAKAR Fair Value Analysis — Data Sources & Coverage

Sakar Healthcare financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine SAKAR quarterly trends for recent quarterly revenue, profit and EPS trends.

Methods Used
8
Data Year
2025
Sector
Healthcare

Available Data Sources: Financial statements, balance sheet data , sector comparisons.

Data Currency: Financial data is from the previous year (2025).

SAKAR vs Healthcare Sector Peers — P/E, P/B & Market Cap

Sakar Healthcare P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Sanofi Consumer Healthca… SANOFICONR 43.83 27.4 ₹10,638
Murae Organisor MURAE 2.86 0.2 ₹41
Sat Kartar Shopping SATKARTAR 29.05 5.53 ₹307
Jeena Sikho Lifecare JSLL 40.04 22.87 ₹8,290
Accretion Pharmaceuticals ACCPL 10.92 1.65 ₹78

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.